top of page

Teplizumab: The First Drug That Changes Type 1 Diabetes

Writer: Zarina Ali
Zarina Ali
Jun 27
3 min read

For more than 100 years, insulin has been the primary treatment for Type 1 Diabetes. While insulin allows people with T1D to live healthy and active lives, it does not stop the autoimmune process that causes the disease. That is why the approval of teplizumab (brand name Tzield) has been considered one of the most significant breakthroughs in Type 1 Diabetes since the discovery of insulin itself.


Image source: Provention Bio
Image source: Provention Bio

What Is Teplizumab?


Teplizumab is an immunotherapy drug designed to target the autoimmune attack responsible for Type 1 Diabetes. In people with T1D, the immune system mistakenly attacks and destroys insulin-producing beta cells in the pancreas. As more beta cells are lost, the body becomes unable to produce enough insulin on its own.

Unlike insulin, which replaces a hormone the body can no longer make, teplizumab works by changing how the immune system behaves. The drug helps reduce the immune system's attack on beta cells, allowing them to survive longer.


Why Is It Such a Big Deal?


Teplizumab became the first FDA-approved treatment shown to delay the progression of Type 1 Diabetes. Researchers found that the drug can postpone the development of clinical, insulin-dependent Type 1 Diabetes by an average of about two to three years in people identified as being at high risk.

This may not sound like a long time, but for a child or teenager, two to three additional years without daily insulin injections, carb counting, and constant glucose monitoring can be incredibly meaningful. It also gives researchers more time to develop future treatments and potential cures.


How Is It Given?


Teplizumab is not a pill or a pump. Instead, it is administered through an intravenous (IV) infusion once daily for 14 consecutive days. During treatment, healthcare providers closely monitor patients for side effects and immune-system changes.


Recent Developments


Research on teplizumab continues to expand. In June 2026, the FDA approved a new use for Tzield in certain children and teens who have recently been diagnosed with Stage 3 Type 1 Diabetes. The goal is to help preserve insulin production and slow the loss of remaining beta-cell function. This marked the first disease-modifying therapy approved for newly diagnosed pediatric patients with Type 1 Diabetes.


Is It a Cure?


No. Teplizumab is not a cure for Type 1 Diabetes.


The drug does not permanently stop the disease, nor does it eliminate the need for insulin in people who already have established T1D. However, it represents something that researchers have been pursuing for decades: a treatment that changes the course of the disease itself rather than simply managing symptoms.


Many experts view teplizumab as proof that immune-based therapies can work. This has encouraged further research into treatments that could preserve beta cells for longer periods or potentially prevent Type 1 Diabetes altogether.


Looking Ahead


Teplizumab may be remembered as the first step toward a future where Type 1 Diabetes can be prevented, delayed, or even stopped before significant beta-cell damage occurs. While insulin remains essential for millions of people living with T1D today, teplizumab has shown that changing the disease itself is possible.

For the first time, researchers are not just treating Type 1 Diabetes—they are learning how to intervene in the disease process itself. That is why teplizumab is considered one of the most important Type 1 Diabetes breakthroughs of the 21st century.


Research in 60 Seconds


What is it?

An immune-system therapy that helps protect insulin-producing beta cells.


Why does it matter?

It is the first drug shown to delay the progression of Type 1 Diabetes.


How is it given?

A 14-day IV infusion treatment.


Is it a cure?

No, but it is the first treatment that changes the course of the disease itself.


Why is it exciting?

It opens the door to future therapies that may one day prevent or stop Type 1 Diabetes altogether.

 
 
 

Comments


bottom of page